News and Investigations

We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.

NextGen Healthcare Under Investigation for Data Breach of One Million Patient Records

We are investigating a data breach impacting more than one million patient records in the custody of NextGen Healthcare, Inc., an electronic health record software provider.

InvestigationsSkylar SchoemigMay 11, 2023Shareholder Derivative, Investigations

ZOLL Medical Corporation Faces Class Action Investigation for Data Breach Impacting More Than 1 Million Individuals

We are investigating the conduct of Zoll Medical Corporation concerning the February 2023 data breach.

InvestigationsSkylar SchoemigMarch 22, 2023Shareholder Derivative, Investigations

Reventics Inc. Faces Class Action Investigation for Failure to Adequately Protect or Notify Customers of Medical Data Breach

We are investigating the conduct of Reventics Inc. for allegedly waiting nearly three months before notifying more than 250,000 consumers that a medical data breach allowed hackers to access their personal and medical information.

InvestigationsSkylar SchoemigMarch 15, 2023Shareholder Derivative, Investigations

Trader Joe’s Faces Class Action Investigation for Allegedly Selling Dark Chocolate Bars with High Levels of Lead and Cadmium

We are investigating the conduct of Trader Joe’s for allegedly selling two chocolate bars––the Trader Joe’s Dark Chocolate 72% Cacao bar and the Trader Joe’s Dark Chocolate Lover’s Chocolate 85% Cacao bar––that contain levels of two heavy metals that exceed California's maximum allowable dose.

InvestigationsSkylar SchoemigMarch 13, 2023Shareholder Derivative, Investigations

Axsome Therapeutics, Inc. (AXSM) Officers and Directors Face Shareholder Investigation for Alleged Securities Law Violations

We are investigating potential derivative claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) relating to securities law violations and unlawful business practices.

InvestigationsSkylar SchoemigMarch 10, 2023Shareholder Derivative, Investigations